Skip to main content
Figure 2 | Breast Cancer Research

Figure 2

From: Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study

Figure 2

Kaplan-Meier plots of recurrence risk over time in all patients. (a) Risk of recurrence was increased for patients exhibiting CCND1-amplified breast cancers compared with nonamplified. (b), (c) No significant difference was observed between varying intensities of cytoplasmic or nuclear cyclin D1. (d) Patients showing a nuclear fraction of cyclin D1 lower than 1% had an increased risk of recurrence compared with higher expression.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us